Continuous flow left ventricular assist devices (CF-LVADs) generally operate at a constant speed, which causes a decrease in pulse pressure and pulsatility in the arteries and allegedly may lead to late complications such as aortic insufficiency and gastrointestinal bleeding. The purpose of this study is to increase the arterial pulse pressure and pulsatility while obtaining more physiological hemodynamic signals, by controlling the CF-LVAD flow rate.
Methods
A lumped parameter model was used to simulate the cardiovascular system including the heart chambers, heart valves, systemic and pulmonary arteries and veins. A baroreflex model was used to regulate the heart rate and a model of the Micromed DeBakey CF-LVAD (Micromed Technology, Houston, TX, USA) to simulate the pump dynamics at different operating speeds. A model simulating the flow rate through the aortic valve served as reference model. CF-LVAD operating speed was regulated by applying proportional-integral (PI) control to the pump flow rate. For comparison, the CF-LVAD was also operated at a constant speed, equaling the mean CF-LVAD speed as applied in pulsatile mode.
Results
In different operating modes, at the same mean operating speeds, mean pump output, mean arterial pressure, end-systolic and end-diastolic volume and heart rate were the same over the cardiac cycle. However, the arterial pulse pressure and index of pulsatility increased by 50% in the pulsatile CF-LVAD support mode with respect to constant speed pump support.
Conclusions
This study shows the possibility of obtaining more physiological pulsatile hemodynamics in the arteries by applying output-driven varying speed control to a CF-LVAD.
FrazierO.H.Unforeseen consequences of therapy with continuous-flow pumps. Circ Heart Fail.2010; 3(6): 647–649.
2.
ThohanV., StetsonS.J., NaguehS.F.Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices. J Heart Lung Transplant.2005; 24(5): 566–575.
3.
KlotzS., StypmannJ., WelpH.Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?Ann Thorac Surg.2006; 82(5): 1774–1778.
4.
VenturaP.A., AlharethiR., BudgeD.Differential impact on post-transplant outcomes between pulsatile- and continuous-flow left ventricular assist devices. Clin Transplant.2011; 25(4): E390–E395.
5.
SaitoS., WestabyS., PiggotD.End-organ function during chronic nonpulsatile circulation. Ann Thorac Surg.2002; 74(4): 1080–1085.
6.
LetsouG.V., ConnellyJ.H., DelgadoRMIIIIs native aortic valve commissural fusion in patients with long-term left ventricular assist devices associated with clinically important aortic insufficiency?J Heart Lung Transplant.2006; 25(4): 395–399.
7.
CrowS., JohnR., BoyleA.Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg.2009; 137(1): 208–215.
8.
NishimuraT., TatsumiE., TakaichiS.Prolonged nonpulsatile left heart bypass with reduced systemic pulse pressure causes morphological changes in the aortic wall. Artif Organs.1998; 22(5): 405–410.
9.
NishimuraT., TatsumiE., NishinakaT., TaenakaY., TakanoH.Aortic reaction to prolonged nonpulsatile left heart bypass. J Artif Organs.1999; 2(2): 141–145.
10.
WilsonE., MaiQ., SudhirK., WeissR.H., IvesH.E.Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF. J Cell Biol.1993; 123(3): 741–747.
11.
AmirO., RadovancevicB., DelgadoRMIIIPeripheral vascular reactivity in patients with pulsatile vs axial flow left ventricular assist device support. J Heart Lung Transplant.2006; 25(4): 391–394.
12.
GokceN., KeaneyJ.F.Jr., HunterL.M.Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol.2003; 41(10): 1769–1775.
13.
GeisenU., HeilmannC., BeyersdorfF.Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg.2008; 33(4): 679–684.
14.
CrowS., ChenD., MilanoC.Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg.2010; 90(4): 1263–1269, discussion 1269.
15.
MalehsaD., MeyerA.L., BaraC., StrüberM.Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Eur J Cardiothorac Surg.2009; 35(6): 1091–1093.
16.
CrowS., MilanoC., JoyceL.Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients. ASAIO J.2010; 56(5): 441–445.
17.
GarciaS., KandarF., BoyleA.Effects of pulsatile- and continuous-flow left ventricular assist devices on left ventricular unloading. J Heart Lung Transplant.2008; 27(3): 261–267.
18.
SandnerS.E., ZimpferD., ZrunekP.Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices. J Heart Lung Transplant.2008; 27(5): 469–473.
19.
LeeJ.J., TymlK., MenkisA.H., NovickR.J., MckenzieF.N.Evaluation of pulsatile and nonpulsatile flow in capillaries of goat skeletal muscle using intravital microscopy. Microvasc Res.1994; 48(3): 316–327.
20.
BabaA., DobsakP., MochizukiS.Evaluation of pulsatile and nonpulsatile flow in microvessels of the bulbar conjunctiva in the goat with an undulation pump artificial heart. Artif Organs.2003; 27(10): 875–881.
21.
LoebeM., KosterA., SängerS.Inflammatory response after implantation of a left ventricular assist device: comparison between the axial flow MicroMed DeBakey VAD and the pulsatile Novacor device. ASAIO J.2001; 47(3): 272–274.
22.
OotakiC., YamashitaM., OotakiY.Reduced pulsatility induces periarteritis in kidney: role of the local renin-angiotensin system. J Thorac Cardiovasc Surg.2008; 136(1): 150–158.
23.
ÜndarA.Myths and truths of pulsatile and nonpulsatile perfusion during acute and chronic cardiac support. Artif Organs.2004; 28(5): 439–443.
24.
ÜndarA.Benefits of pulsatile flow during and after cardio-pulmonary bypass procedures. Artif Organs.2005; 29(9): 688–690.
25.
GuanY., KarkhanisT., WangS.Physiologic benefits of pulsatile perfusion during mechanical circulatory support for the treatment of acute and chronic heart failure in adults. Artif Organs.2010; 34(7): 529–536.
26.
CoxL.G.E., LoerakkerS., RuttenM.C.M., de MolBAJM, van de VosseF.N.A mathematical model to evaluate control strategies for mechanical circulatory support. Artif Organs.2009; 33(8): 593–603.
27.
ShiY., LawfordP.V., HoseD.R.Numerical modeling of hemodynamics with pulsatile impeller pump support. Ann Biomed Eng.2010; 38(8): 2621–2634.
28.
AndoM., TakewaY., NishimuraT.A novel counterpulsation mode of rotary left ventricular assist devices can enhance myocardial perfusion. J Artif Organs.2011; 14(3): 185–191.
29.
IsingM., WarrenS., SobieskiA.M., SlaughterM.S., KoenigS.C., GiridharanG.A.Flow modulation algorithms for continuous flow left ventricular assist devices to increase vascular pulsatility: a computer simulation study. Cardiovascular Engineering and Technology.2011; 2(2): 90–100.
30.
VandenbergheS., SegersP., SteendijkP.Modeling ventricular function during cardiac assist: does time-varying elastance work?ASAIO J.2006; 52(1): 4–8.
31.
VandenbergheS., SegersP., AntakiJ.F., MeynsB., VerdonckP.R.Hemodynamic modes of ventricular assist with a rotary blood pump: continuous, pulsatile, and failure. ASAIO J.2005; 51(6): 711–718.
32.
KhalilH.A., KerrD.T., SchustermanMAII, CohnW.E., FrazierO.H., RadovancevicB.Induced pulsation of a continuous-flow total artificial heart in a mock circulatory system. J Heart Lung Transplant.2010; 29(5): 568–573.
33.
BovendeerdP.H., BorsjeP., ArtsT., van De VosseF.N.Dependence of intramyocardial pressure and coronary flow on ventricular loading and contractility: a model study. Ann Biomed Eng.2006; 34(12): 1833–1845.
34.
De PaterL., Van Den BergJ.W.An electrical analogue of the entire human circulatory system. Med Electron Biol Eng.1964; 2: 161–166.
35.
UrsinoM.Interaction between carotid baroregulation and the pulsating heart: a mathematical model. Am J Physiol.1998; 275(5 Pt. 2): 1733–1747.
36.
FresielloL., KhirA.W., Di MolfettaA., KozarskiM., FerrariG.Effects of Intra-Aortic Balloon Pump Timing on Baroreflex Activities in a Closed Loop Cardiovascular Hybrid Model. Artif Organs.2013; 37(3): 237–247.
37.
MoscatoF., DanieliG.A., SchimaH.Dynamic modeling and identification of an axial flow ventricular assist device. Int J Artif Organs.2009; 32(6): 336–343.
DarowskiM., De LazzariC., FerrariG., ClementeF., GuaragnoM.The influence of simultaneous intra-aortic balloon pumping and mechanical ventilation on hemodynamic parameters—numerical simulation. Front Med Biol Eng.1999; 9(2): 155–174.
40.
De LazzariC., DarowskiM., FerrariG., ClementeF., GuaragnoM.Computer simulation of haemodynamic parameters changes with left ventricle assist device and mechanical ventilation. Comput Biol Med.2000; 30(2): 55–69.
41.
FerreiraA., ChenS., SimaanM.A., BostonJ.R., AntakiJ.F.A nonlinear state-space model of a combined cardiovascular system and a rotary pump. Proceedings of the 44th IEEE Conference on Decision and Control, and the 2005 European Control Conference, CDC-ECC, 12–15 Dec 2005. Sevilla, Spain, 2005; 897–902.
42.
SalamonsenR.F., LimE., GaddumN.Theoretical foundations of a Starling-like controller for rotary blood pumps. Artif Organs.2012; 36(9): 787–796.
43.
HeldtT., ShimE.B., KammR.D., MarkR.G.Computational modeling of cardiovascular response to orthostatic stress. J Appl Physiol (1985).2002; 92(3): 1239–1254.
44.
KlotzS., DengM.C., StypmannJ.Left ventricular pressure and volume unloading during pulsatile versus nonpulsatile left ventricular assist device support. Ann Thorac Surg.2004; 77(1): 143–149, discussion 149–150.
45.
SlaughterM.S.Long-term continuous flow left ventricular assist device support and end-organ function: prospects for destination therapy. J Card Surg.2010; 25(4): 490–494.
La VecchiaL., ZanollaL., VarottoL.Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction. Am Heart J.2001; 142(1): 181–189.
